Day: January 8, 2025

Publication of offer document for Nykredit’s recommended voluntary public tender offer for Spar Nord Bank A/S – Nykredit Realkredit A/S

Written by Customer Service on January 8, 2025. Posted in Mergers And Acquisitions.

THIS ANNOUNCEMENT IS PUBLISHED PURSUANT TO SECTION 4(2) OF EXECUTIVE ORDER NO. 636 OF 15 MAY 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. Publication of offer document for Nykredit’s recommended voluntary public tender offer for Spar Nord Bank A/S 8 January 2025 Nykredit publishes offer document concerning recommended voluntary public tender offer for Spar Nord Bank A/S In accordance with section 4(1) of the Danish Takeover Order1, Nykredit Realkredit A/S (“Nykredit”) announced on 10 December 2024 that Nykredit intended to submit a voluntary public tender offer (the “Offer”) to acquire all shares in Spar Nord Bank A/S (“Spar Nord Bank”), with the exception of Spar Nord Bank’s treasury...

Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth

Written by Customer Service on January 8, 2025. Posted in Earnings Releases And Operating Results.

EXOSENS ANNOUNCES 2024 ESTIMATED RESULTS ABOVE IPO GUIDANCE; 2025 GUIDANCE HIGHLIGHTING LOW TWENTIES ADJUSTED EBITDA GROWTH PRESS RELEASEMÉRIGNAC, FRANCE– 8th JANUARY 20252024 estimated figures showing strong revenue growth and sustained profitability, above guidance provided at IPO Continued strong performance expected in 2025, with revenue growth in the high-teens and adjusted EBITDA growth in the low twenties Overall increased market demand further improves the perspectives which implies a high-teens 2024-2026 adjusted EBITDA CAGRExosens (Ticker: EXENS; ISIN: FR001400Q9V2), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, today publishes full-year 2024 unaudited estimated revenue and adjusted EBITDA, its guidance for full-year 2025 as well as its outlook. 2024...

Transparency notification by Mr Jan Van Geet

Written by Customer Service on January 8, 2025. Posted in Public Companies.

Press ReleaseRegulated InformationAntwerp, 8 January 2024 – 07:00 a.m. CET Disclosure in accordance with the Law of 2 May 2007 – Transparency law Transparency notification by Mr Jan Van Geet VGP NV has received a transparency notification dated 7 January 2025 that (i) Little Rock S.à r.l. now holds 37.85% of the voting rights of VGP NV, and (ii) Tomanvi SCA now holds 2.94% of the voting rights of VGP NV and that therefore together, Jan Van Geet, Little Rock S.à.r.l. and Tomanvi SCA now hold 40.79% of the voting rights of VGP NV. Therefore, their voting rights have crossed the threshold of 40%. The notification dated 7 January 2025 contains the following information:Reason for notification:Passive threshold crossing.Notification by:A parent undertaking or a controlling person.Persons subject to the notification requirement:Jan...

Addex to Present at the 2025 Swiss Equities Baader Conference

Written by Customer Service on January 8, 2025. Posted in Public Companies.

Geneva, Switzerland, January 8, 2025 – Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that Dr Robert Lütjens, Head of Discovery – Biology, will present at the Swiss Equities Baader Conference being held in Bad Ragaz, Switzerland, January 08-10, 2025. In his presentation, Dr Lütjens will provide a corporate update and discuss recent advances from Addex’s CNS pipeline. Presentation Details:Date: Friday, January 10, 2025Time: 11:40 CETConference Venue: Grand Resort Bad RagazRoom: Forum 2 Dr Lütjens will be available for one-on-one meetings throughout the conference. For more information or to schedule a one-on-one meeting, please submit a request via the Baader Conference...

Fiscal Q1 2025 Revenues

Written by Customer Service on January 8, 2025. Posted in Earnings Releases And Operating Results.

Fiscal Q1 2025 Revenues Issy-les-Moulineaux, France – January 8th, 2025 A robust start to the year, in line with the Group’s strategic and financial objectives HighlightsBusiness momentum continuing to be strong in the first quarter, fueled by solid net retention and a development pipeline on track to meet full year objectives Total Revenues grew organically by +13.2% reaching 289 million euros in Fiscal Q1 2025, providing a solid foundation to achieve the low-double-digit growth target for the full year Operating revenue increasing by +12.1% organically up to 249 million euros, driven by Employee Benefits which sustained its strong growth trajectory with +14.9% organic growth Float revenue standing at 40 million euros, continuing to grow compared to Fiscal Q1 2024, as expected Continued execution of the M&A roadmap with...

Basilea provides portfolio update and outlook

Written by Customer Service on January 8, 2025. Posted in Public Companies.

Allschwil, Switzerland, January 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on the progress of its Research & Development portfolio in 2024 and upcoming milestones. David Veitch, Chief Executive Officer, said: “We have achieved several significant milestones in 2024. We partnered with a highly committed, focused and capable company for the commercialization of our anti-MRSA antibiotic, Zevtera, in the United States, following its approval earlier in the year. For our leading antifungal Cresemba, the European Commission expanded the approved uses to include treatment for pediatric patients. This not only made Cresemba available to children, but also extended its protection...

Roche purchases shares in tender offer for Poseida Therapeutics, Inc.

Written by Customer Service on January 8, 2025. Posted in Public Companies.

Basel, 8 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Blue Giant Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of Poseida Therapeutics, Inc. (“Poseida”, NASDAQ: PSTX) at a price of $9.00 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain contingent payments of up to an aggregate of $4.00 per share in cash. The tender offer expired at one minute following 11:59 p.m., New York City time on 7 January, 2025, and was not extended. Citibank, N.A., the depositary for the tender offer, advised Roche that a total of approximately 64,991,586 shares of Poseida’s common stock were validly tendered and not validly withdrawn in the tender...

Exela Technologies, Inc. Announces Intention to Delist its Securities from Nasdaq and to Deregister its Securities under the Securities Exchange Act

Written by Customer Service on January 8, 2025. Posted in Public Companies.

IRVING, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (OTC: XELA, XELAP), a global business process automation leader, informs its stockholders and the market in general that today its Board of Directors approved the commencement of the process to: (i) voluntarily delist its securities from the Nasdaq Stock Market LLC (“Nasdaq”); and (ii) deregister the Company’s securities under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), after taking into account a number of considerations, including, but not limited to, the Nasdaq Suspension (as defined below) and the expected reduction in operating expenses associated with continued listing and reporting. The Company previously reported that, on November 6, 2024, Nasdaq notified the Company that the Nasdaq Hearings...

Micron Breaks Ground on New HBM Advanced Packaging Facility in Singapore

Written by Customer Service on January 8, 2025. Posted in Public Companies.

Approximate $7 billion investment over the next several years to meet AI data center demand SINGAPORE, Jan. 08, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) broke ground today on a new High-Bandwidth Memory (HBM) advanced packaging facility adjacent to the company’s current facilities in Singapore. Micron marked the occasion with a ceremony attended by Gan Kim Yong, Deputy Prime Minister and Minister for Trade and Industry of Singapore, Png Cheong Boon, Chairman of the Singapore Economic Development Board, Pee Beng Kong, Executive Vice President of the Singapore Economic Development Board, and Tan Boon Khai, CEO of JTC Corporation. The new HBM advanced packaging facility will be the first facility of its kind in Singapore. Operations for the new facility are scheduled to begin in 2026, with meaningful expansion...

Himax and AUO Partner to Showcase Revolutionary AmLED® Integrated Automotive Display Platform at CES 2025

Written by Customer Service on January 8, 2025. Posted in Public Companies.

Combining AUO’s Display HMI and Himax’s Most Comprehensive Automotive IC Technologies to Shape the Future of Smart, Sustainable In-Car Displays TAINAN, Taiwan, Jan. 07, 2025 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX), an industry leader in fabless display driver ICs and semiconductors, and AUO Corporation (“AUO”) (TWSE: 2409), a technology-driven company advancing the frontier of display innovation, today announced their collaboration to showcase AUO’s groundbreaking Display HMI—AmLED® integrated automotive display platform, featuring Himax’s advanced automotive IC solutions at CES 2025. Together, AUO and Himax form an intelligent automotive display platform that sets new benchmarks for clarity, functionality, and sustainability in smart cockpit experiences for modern vehicles. As the automotive...

Day: January 8, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals